74
3
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T67830 | p38α inhibitor 3 | p38 MAPK | |
p38α inhibitor 3 is a inhibitor of the mitogen-activated protein kinase p38α that can block the effectiveness of myoblast differentiation. | |||
T78652 | p38α inhibitor 4 | p38 MAPK | |
p38α inhibitor 4 is a selective MAPK p38α inhibitor, which is used to study diabetes, pain and chronic inflammation. | |||
T36012 | p38α inhibitor 2 | ||
P38α Inhibitor 2, a potent and selective inhibitor of p38α MAPK, exhibits a pIC50 value of 9.6. It also demonstrates inhibition of the hERG ion channel (IC50=27 μM) and maintains promising selectivity, with <30% inhibiti... | |||
T7661 | SD-169 | SD 169 | p38 MAPK |
SD-169 (SD 169) is a selective and ATP competitive the MAP kinases p38α and p38β inhibitor. | |||
T13018 | SU3327 | halicin | JNK |
SU3327 (halicin) is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM). | |||
T12997 | SR-318 | p38 MAPK , TNF | |
SR-318 is a potent and highly selective inhibitor of p38 MAPK(IC50s of 5 nM, 32 nM and 6.11 μM for p38α, p38β and p38α/β, respectively), has anti-cancer and anti-inflammatory activity. | |||
T12347 | P38-α MAPK-IN-1 | p38 MAPK , Autophagy | |
p38-α MAPK-IN-1 is a MAPK14 (p38-α) inhibitor(IC50 of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay). | |||
T16812 | RWJ-67657 | JNJ 3026582 | p38 MAPK |
RWJ-67657 (JNJ 3026582) is an orally active and selective p38α and p38β MAPK inhibitor (IC50s: 1 and 11 μM, respectively). RWJ-67657 shows no activity at p38γ and p38δ and shows a cardioprotective effect. | |||
T6496 | Vactosertib | TEW-7197,EW-7197 | ALK , TGF-beta/Smad |
Vactosertib (EW-7197) is an orally bioavailable inhibitor of the serine/threonine kinase, transforming growth factor (TGF)-beta receptor type 1 (TGFBR1), also known as activin receptor-like kinase 5 (ALK5), with potentia... | |||
T6927 | Pamapimod | R1503,Ro4402257 | p38 MAPK , Autophagy |
Pamapimod (R1503) (R-1503, Ro4402257) is a novel, selective inhibitor of p38 mitogen-activated protein kinase. It inhibits p38α and p38β enzymatic activity with IC50 values of 0.014±0.002 and 0.48± 0.04 microM, respectiv... | |||
T5494 | MW-150 | MW01-18-150SRM | p38 MAPK , Autophagy |
MW-150 (MW01-18-150SRM) is a unique protein kinase inhibitor, is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM. | |||
T6089 | Neflamapimod | VX-745 | p38 MAPK , Autophagy |
Neflamapimod (VX-745) , a specific and effective inhibitor of p38α(IC50=10 nM), is 22-fold greater specificity against p38β and no inhibition activity to p38γ. | |||
T2513 | VX-702 | p38 MAPK , Autophagy | |
VX-702 is a highly specific p38α MAPK inhibitor, 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifical... | |||
T12871 | Talmapimod | SCIO-469 | p38 MAPK |
Talmapimod (SCIO-469) is an selective, orally active, and ATP-competitive p38α inhibitor with IC50 of 9 nM and 90 nM for p38α and p38β, respectively. Talmapimod exhibits at least 2000-fold selectivity over a panel of 20 ... | |||
T7367 | Acumapimod | BCT-197 | p38 MAPK , Autophagy |
Acumapimod (BCT-197) is an orally active inhibitor of p38α MAPK (IC50 <1 μM). | |||
T3462 | BMS-582949 hydrochloride | BMS-582949 HCl | p38 MAPK , Autophagy |
The BMS-582949 hydrochloride (BMS-582949 HCl) is a highly specific p38α MAPK inhibitor (IC50: 13 nM). | |||
T1974 | PH-797804 | PH797804 | p38 MAPK , Autophagy |
PH-797804 is a pyridinone inhibitor of p38α (IC50: 26 nM, in a cell-free assay); 4-fold more selective versus p38β and does not inhibit JNK2. | |||
T2277 | Losmapimod | GSK-AHAB,GW856553X,GW856553,SB856553 | p38 MAPK , Autophagy |
Losmapimod (GSK-AHAB) (GW856553X; SB856553; GSK-AHAB) is a specific, potent, and orally active p38 MAPK inhibitor (pKi: 8.1/7.6 for p38α/β). | |||
T10277 | AL 8697 | p38 MAPK | |
AL 8697 is a selective p38α MAPK inhibitor (IC50 = 6 nM) with 14-fold selectivity over p38β (IC50 = 82 nM) and 300-fold selectivity over a panel of 91 kinases. AL 8697 has anti-inflammatory activity. | |||
T6150 | TAK-715 | p38 MAPK , Casein Kinase , JNK | |
TAK-715 is a p38 MAPK inhibitor for p38α. | |||
T2301 | SB 202190 | FHPI,SB202190 | Apoptosis , p38 MAPK , Autophagy |
SB 202190 (FHPI) is a p38 MAPK inhibitor that inhibits p38α and p38β2 (IC50=50/100 nM) selectively and cell-permeably. SB 202190 has antitumor activity and also induces the differentiation of human embryonic stem cells i... | |||
T7667 | R1487 | p38 MAPK | |
R1487 is an orally bioavailable and highly selective p38α mitogen-activated protein kinase inhibitor. | |||
T4597 | UM-164 | UM164,DAS-DFGO-II | p38 MAPK , Src , Autophagy |
UM-164 (DAS-DFGO-II), a highly potent c-Src inhibitor with a dissociation constant (Kd) of 2.7 nM, also effectively inhibits p38α and p38β. | |||
T9581 | ARRY-797 | ARRY-371797 | IL Receptor , p38 MAPK |
ARRY-797 (ARRY-371797) is a potent and selective p38α inhibitor and inhibits LPS-Induced IL-6. | |||
T15572 | IN-1130 | ALK | |
IN-1130 is a selective inhibitor of ALK5 with IC50 values of 5.3 nM, 36 nM, and 4.3 μM for phosphorylation of ALK5-mediated Smad3, ALK5 phosphorylation of casein and p38α mitogen-activated protein kinase. | |||
T63067 | Emprumapimod | ||
Emprumapimod is a selective, orally active inhibitor of p38α MAPK. emprumapimod acts on RPMI-8226 cells and directly inhibits LPS-induced IL-6 production with an IC50 value of 100 pM. emprumapimod can be used to study di... | |||
T2293 | SGX-523 | Raf , p38 MAPK , c-Met/HGFR , Bcr-Abl | |
SGX-523 is a selective Met inhibitor (IC50: 4 nM), no inhibitory to Abl, BRAFV599E, p38α, and c-Raf. | |||
T1953 | L-779450 | L 779450 | Raf , Autophagy |
L-779450, an effective, ATP-competitive Raf kinase inhibitor (IC50: 10 nM) , displays > 7, > 30 and > 70-fold selectivity over p38α, GSK3β and Lck respectively. | |||
T7123 | AMG-47a | VEGFR , p38 MAPK , JAK , Src | |
AMG-47a is a potent inhibitor of Lck and T cell proliferation. AMG-47a could promote the degradation of the KRAS oncoprotein. AMG-47a selectively reduced the levels of EGFP-KRASG12V protein but did not affect EGFP protei... | |||
T6784 | BI-78D3 | JNK | |
BI-78D3, a competitive JNK inhibitor. IC50 of BI-78D3 is 280 nM that displays > 100 fold selectivity over p38α, and have no activity at mTOR and PI-3K. | |||
T6380 | AMG 900 | AMG900,AMG-900 | p38 MAPK , Tyrosine Kinases , Aurora Kinase |
AMG 900 is a potent and highly selective pan-Aurora kinases inhibitor for Aurora A/B/C with IC50 of 5 nM/4 nM /1 nM. It is >10-fold selective for Aurora kinases than p38α, Tyk2, JNK2, Met and Tie2. Phase 1. | |||
T6976 | SB 239063 | SB239063 | p38 MAPK , Autophagy |
SB 239063 (SB239063) is a potent and selective p38 MAPKα/β inhibitor with IC50 of 44 nM, showing no activity against the γ- and δ-kinase isoforms. | |||
T1811 | WH-4-023 | KIN112,KIN001-112,Dual LCK/SRC inhibitor | Src |
WH-4-023 (Dual LCK/SRC inhibitor) is a potent and orally active Lck/Src inhibitor. It also potently inhibits SIK. | |||
T7276 | SD 0006 | SD-06 | p38 MAPK , Autophagy |
SD 0006 (SD-06) is a MAPK p38 alpha inhibitor( IC50 : 110 nM) for the treatment of arthritis. | |||
T38752 | EW-7195 | ALK , TGF-beta/Smad | |
EW-7195 is a selective and potent inhibitor of ALK5 (TGFβR1) with an IC50 value of 4.83 nM.EW-7195 has an affinity for ALK5 that is more than 300-fold higher than that of p38α.EW-7195 has an inhibitory effect on TGF-β1-i... | |||
T68134 | Ro-3201195 | p38 MAPK | |
Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity. | |||
T6047 | Ralimetinib dimesylate | LY2228820 dimesylate,Ralimetinib,LY2228820,Ralimetinib Mesylate | Apoptosis , p38 MAPK , Autophagy |
Ralimetinib dimesylate (LY2228820 dimesylate) is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available, p38 mitogen-activated protein kinase (MAPK) inhibitor with potential an... | |||
T6130 | Skepinone-L | CBS3830 | p38 MAPK , Autophagy |
Skepinone-L (CBS3830) is a selective p38 mitogen-activated protein kinase inhibitor. | |||
T7162 | R1487 Hydrochloride | R1487 (Hydrochloride) | p38 MAPK , Autophagy |
R1487 Hydrochloride (R1487 (Hydrochloride)) is an orally bioavailable and highly selective inhibitors of p38α. | |||
T39343 | MW-150 hydrochloride | MW01-18-150SRM hydrochloride,MW-150 hydrochloride | |
MW-150 hydrochloride (MW01-18-150SRM hydrochloride) is a potent and selective inhibitor of p38α MAPK, with a Ki value of 101 nM. It exhibits excellent CNS penetration and oral bioavailability. MW-150 hydrochloride (MW01-... | |||
T23408 | SX 011 | Others | |
SX 011 is a p38α inhibitor. | |||
T12871L | Talmapimod hydrochloride | SCIO-469 hydrochloride | p38 MAPK |
Talmapimod hydrochloride is a selective and ATP-competitive p38α inhibitor (IC50: 9 nM). It also shows about 10-fold selectivity over p38β, and at least 2000-fold selectivity over a panel of 20 other kinases, including o... | |||
T18682 | SJFδ | Others | |
SJFδ is a 10-atom linker PROTAC. SJFδ degrades p38δ with a DC50 of 46.17 nM, but does not degrade p38α, p38β, or p38γ[1]. | |||
T36017 | PF-05381941 | ||
PF-05381941 is a potent dual inhibitor of TAK1/p38α, with IC50s of 156 and186 nM, respectively[1]. PF-05381941 inhibits LPS-stimulated release of TNF-αfrom human peripheralmononuclear (PMN) cells with an IC50 of 8 nM[1].... | |||
T22765 | EO 1428 | Others | |
p38α and p38β2 inhibitor | |||
T22885 | JX 401 | Others | |
JX 401 is a p38α inhibitor. | |||
T72202 | Anti-inflammatory agent 33 | ||
Anti-inflammatory agent 33, a potent p38α inhibitor, effectively reduces NO production and suppresses LPS-induced expression of iNOS, COX-2, p-p38α, and p-MK2 proteins, thereby demonstrating anti-inflammatory activity. | |||
T16477 | PF-03715455 | p38 MAPK | |
PF-03715455 potently inhibits LPS-induced TNFα production in human whole blood (IC50=1.7 nM). PF-03715455 is an effective inhibitor of inhaled p38 MAPK. PF-03715455 displays some selectivity for p38α over p38β (respectiv... | |||
T16721 | Ralimetinib | LY2228820 | Others |
Ralimetinib selectively inhibits phosphorylation of MK2 (Thr334) and has no effect on phosphorylation of p38α MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc. Ralimetinib is an effective and selective, ATP-competitive inhibitor... | |||
T28993 | TOP1210 | TOP 1210,TOP-1210 | |
TOP1210, a narrow spectrum kinase inhibitor, potently inhibits P38α, Src, and Syk kinase activities. |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPY-04260 | P38 Protein, Human, Recombinant (His) | Human | Baculovirus-Insect Cells |
MAPK14 contains 1 protein kinase domain and belongs to the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular processes such as prol... | |||
TMPK-00351 | RANK/TNFRSF11A Protein, Human, Recombinant (aa 30-212, hFc) | Human | HEK293 |
TNFRSF11A, also known as receptor activator of NF-κB (RANK), activates several signaling pathways, such as NF-κB, JNK, ERK, p38α, and Akt/PKB. RANK/TNFRSF11A is a novel and frequent target for de novo methylation in glio... | |||
TMPK-00723 | RANK/TNFRSF11A Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 |
TNFRSF11A, also known as receptor activator of NF-κB (RANK), activates several signaling pathways, such as NF-κB, JNK, ERK, p38α, and Akt/PKB. RANK/TNFRSF11A is a novel and frequent target for de novo methylation in glio... |